Study of breast cancer prevention in BRCA1/2 mutation carriers
Part of Cancer, Skin clinical trials.
This is an observational study that looks at how different cancer prevention approaches affect women with harmful (deleterious) BRCA1 or BRCA2 mutations. It may help improve future prevention and follow-up plans for women at higher inherited risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You agree to join by signing informed consent
- You have a confirmed harmful inherited BRCA1 and/or BRCA2 mutation
- You have one of these situations: no cancer history, breast cancer that was treated with curative intent, or stage IV breast cancer diagnosed after the BRCA1/2 test
- You were seen at the study center starting in 2010 (or after the site started recruiting for the prospective group)
- You did not have another cancer in the last 5 years before your BRCA1/2 mutation test (with limited exceptions like early ovarian cancer, certain skin cancers, melanoma in situ, or CIS of the cervix)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to use your genetic information (along with your family history) to better understand your personal risk for breast cancer. The goal is to see if giving this risk report to women with higher genetic risk can help them and their doctors make more informed decisions about screening and prevention.
This study examines how different molecular subtypes (patterns of genes and proteins) of breast cancer behave in people with BRCA1 or BRCA2 mutations. By studying tumor samples and medical records, researchers hope to better predict which treatments will work best and predict long-term outcomes for BRCA-positive breast cancer patients.
This study looks at genetic and other factors in people with certain cancers to better understand personal cancer risks and improve monitoring. It may help find ways to detect changes earlier.
This study follows women who carry gene mutations that increase ovarian cancer risk to understand how preventive surgery affects their health, quality of life, and peace of mind. Researchers will track your outcomes over 3 years to help inform future treatment decisions for others at similar risk.
This study collects blood (and possibly tumor tissue) to learn how certain inherited gene changes relate to breast and ovarian cancer risk. It may help researchers understand which people are most likely to develop these cancers and how tumors differ in high-risk patients.
This study looks at fertility in women who carry a BRCA1 or BRCA2 gene mutation. It aims to understand how these mutations might affect a woman's ability to have children by comparing them to family members without the mutation.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.